| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SSH1 |
SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 |
26.600 |
Evidence |
|
| DDX3Y |
DDX3Y, DBY: ATP-dependent RNA helicase DDX3Y |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
26.580 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
26.580 |
Evidence |
O
|
| ABCB11 |
ABCB11, BSEP: Bile salt export pump |
ABCD1 |
ABCD1, ALD: ATP-binding cassette sub-family D member 1 |
26.550 |
Evidence |
|
| ABCD1 |
ABCD1, ALD: ATP-binding cassette sub-family D member 1 |
PEX19 |
PEX19, HK33, OK/SW-cl.22, PXF: Peroxisomal biogenesis factor 19 |
26.550 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
26.470 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
26.470 |
Evidence |
O
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
26.470 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
26.470 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
26.470 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
26.470 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
TERF2IP |
TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 |
26.470 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
26.470 |
Evidence |
|
| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
26.470 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
26.470 |
Evidence |
|
| VAMP2 |
VAMP2, SYB2: Vesicle-associated membrane protein 2 |
STX5A |
IPI00386786 |
26.460 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
26.440 |
Evidence |
O
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
MUSK |
MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor |
26.410 |
Evidence |
|
| C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
C8B |
C8B: Complement component C8 beta chain precursor |
26.400 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
26.400 |
Evidence |
|
| CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
AQP5 |
AQP5: Aquaporin-5 |
26.380 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
26.230 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
PRG2 |
PRG2, MBP: Bone marrow proteoglycan precursor |
26.230 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
26.230 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
26.230 |
Evidence |
|
